Tuberculosis Is A Threat To Global Health Security
4 SEP - Heads of state gather this month for the United Nations (UN) General Assembly on tuberculosis, the first time in the disease’s 3,000-year history that such a high-level meeting has been held. So why hold one now?
Q&A: DIAGNOSTIC ADVICE FOR LOW-RESOURCE SETTINGS
4 SEP - We interviewed Dr Cassandra Kelly-Cirino, Head of AMR and Outbreaks at the Foundation for Innovative New Diagnostics (FIND(link is external)) – an international non-profit organisation that accelerates the development, evaluation and delivery of high-quality, affordable diagnostic tests for poverty-related diseases – about the challenges faced in this domain.
Impact, economic evaluation, and sustainability of integrated vector management in urban settings to prevent vector-borne diseases: a scoping review
3 SEP - The control of vector-borne diseases (VBD) is one of the greatest challenges on the global health agenda. Rapid and uncontrolled urbanization has heightened the interest in addressing these challenges through an integrated vector management (IVM) approach. The aim was to identify components related to impacts, economic evaluation, and sustainability that might contribute to this integrated approach to VBD prevention.
'It’s not if, it’s when': the deadly pig disease spreading around the world
3 SEP - Swine fever has made its way into China, home to half the world’s pigs. Farmers in Estonia are already counting the cost
The effectiveness of influenza vaccination against medically-attended illnesses in Hong Kong across three years with different degrees of vaccine match, 2014–17
3 SEP - Objective: To evaluate influenza VE against medically-attended illness in different age groups and against specific influenza types/subtypes in Hong Kong.
Interventions for vector-borne diseases focused on housing and hygiene in urban areas: a scoping review
3 SEP - Over half the world’s human populations are currently at risk from vector-borne diseases (VBDs), and the heaviest burden is borne by the world’s poorest people, communities, and countries. The aim of this study was to conduct a review on VBD interventions relevant to housing and hygiene (including sanitation and waste management) in urban areas.
Supporting and strengthening research on urban health interventions for the prevention and control of vector-borne and other infectious diseases of poverty: scoping reviews and research gap analysis
This paper describes the collaboration and partnership of the Special Programme for Research and Training in Tropical Diseases (TDR) hosted by the World Health Organization (WHO) and the “VEctor boRne DiseAses Scoping reviews” (VERDAS) Research Consortium as they joined efforts in response to filling this gap in knowledge and evidence by supporting the development of a series of scoping reviews that highlight priority research gaps and policy implications to address vector-borne and other infectious diseases at the urban level.
WHO SEARO countries to meet in Delhi next week
1 SEP - The member-countries of the WHO's Regional Office for South-East Asia (SEARO), including India, will meet in the first week of September to brainstorm on measures against vector-borne diseases and improving access to essential medicines.
The meeting will be held in Delhi from September 3 to 7 to discuss priority health issues in the region, which is home to one-fourth of the world's population.
Securing the U.S. from its most dangerous invader: infectious disease
31 AUG - The U.S. has a major role to play on the global health security stage. But instead of leading, there are indications that we’re retreating from our responsibility to make the world safer from infectious disease — and at the same time endangering the lives of Americans at home.
Study reveals early impact of 3-strain oral polio vaccine withdrawal
31 AUG - A new analysis of global polio surveillance data covering the first 2 years after withdrawal of oral polio vaccine serotype 2 (OPV2) was withdrawn in 2016 found that Sabin 2 poliovirus (one of the three vaccine strains) in stool and sewage samples declined at 2 months after withdrawal. After a year, however, virus detections continued because of monovalent OPV2 use to stem vaccine-derived poliovirus serotype 2 (VDPV2) outbreaks.